发明名称 FARMACEUTISK TCLF-KOMPOSITION
摘要 Target Cell Lysis Factor (TCLF) is produced by exposing a human cell line capable of producing TCLF to a TCLF inducer to induce TCLF production, and collecting and purifying the accumulated TCLF. The TCLF which is produced includes lymphotoxin and human Tumor Necrosis Factor (hTNF). The hTNF may be separated and purified. The human cell lines are preferably human leucocyte and human lymphoblastoid lines, such as BALL-1, TALL-1, NALL-1 Namalwa, MOLT-3, Mono-1, M-7002, B-7101, JBL, EBV-Sa, EBV-Wa, EBV-HO, BALM 2, CCRF-CEM, DND-41 and CCRF-SB, as well as human cell lines which are obtainable by transforming normal human monocytes, or granulocytes. All of these human cell lines are multipliable by implanting them in a non-human warm-blooded animal, or alternatively, allowing them to multiply in a conventional-type diffusion chamber by which the nutrient body fluid of a non-human warm-blooded animal is supplied to them.
申请公布号 SE9000532(D0) 申请公布日期 1990.02.14
申请号 SE19900000532 申请日期 1990.02.14
申请人 KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO;MOCHIDA SEIYAKU KK 发明人 M * MITSUHASHI
分类号 A61K38/00;C07K14/525;(IPC1-7):C12P21/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址